Advertisement

The Journal of Frailty & Aging

, Volume 7, Issue 3, pp 176–181 | Cite as

Subjective Sleep Quality among Sarcopenic and Non-Sarcopenic Older Adults: Results from the Sarcophage Cohort

  • Médéa Locquet
  • C. Beaudart
  • L. Delandsheere
  • J.-Y. Reginster
  • O. Bruyère
Original Research

Abstract

Background

It seems that sleep quality could impact the physiological process related to loss of muscle mass.

Objective

We seek to compare subjective sleep quality of sarcopenic and non-sarcopenic subjects diagnosed according to 6 definitions.

Design

Cross-sectional data used in this analysis were collected from the SarcoPhAge (Sarcopenia & Physical Impairment with Advancing Age) cohort, a prospective study aiming to assess clinical parameters linked to sarcopenia.

Participants

The present study was interested in community-dwelling older adults with and without sarcopenia. Measurements–A diagnosis of sarcopenia was established according to 6 definitions. Three assessments were carried out: an evaluation of lean mass, a measurement of muscle strength and an assessment of physical performance. In addition, to evaluate the parameters of subjective sleep, we used the Pittsburgh Sleep Quality Index (PSQI), a self-administered questionnaire evaluating 7 components of sleep architecture.

Results

A total of 255 individuals aged 74.7±5.8 years were included. Based on the 6 different definitions, the prevalence of sarcopenia ranged from 5.9% to 32.5%. There was no significant difference between sarcopenic and non-sarcopenic subjects regarding most of the components of subjective sleep quality. However, the definition of Cruz-Jentoft et al. (2010) indicated that sarcopenic subjects had higher scores than non-sarcopenic subjects for two components: sleep latency and day-time dysfunction (p=0.03 and p=0.04, adjusted for confounders). Moreover, some parameters of sleep quality were correlated with components of sarcopenia.

Conclusions

Some properties of subjective sleep quality seem to be associated with sarcopenia and seem correlated with at least one of the three components of the condition.

Key words

Sarcopenia sleep quality older adults 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rosenberg IH. Sarcopenia: origins and clinical relevance. J. Nutr. 1997;127:990–991.CrossRefGoogle Scholar
  2. 2.
    Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A. Biol. Sci. Med. Sci. 2006;61:1059–64.CrossRefPubMedGoogle Scholar
  3. 3.
    Cooper C, Dere W, Evans W, et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos. Int. 2012;23:1839–48.CrossRefPubMedGoogle Scholar
  4. 4.
    Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 1998;147:755–63.CrossRefPubMedGoogle Scholar
  5. 5.
    Delmonico MJ, Harris TB, Lee J-S, et al. Alternative Definitions of Sarcopenia, Lower Extremity Performance, and Functional Impairment with Aging in Older Men and Women. J. Am. Geriatr. Soc. 2007;55:769–74.CrossRefPubMedGoogle Scholar
  6. 6.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. Oxford University Press. 2010;39:412–23.CrossRefGoogle Scholar
  7. 7.
    Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia. J. Am. Med. Dir. Assoc. 2011;12:249–56.CrossRefPubMedGoogle Scholar
  8. 8.
    Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia With Limited Mobility: An International Consensus. J. Am. Med. Dir. Assoc. 2011;12:403–9.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Studenski SA, Peters KW, Alley DE, et al. The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates. Journals Gerontol. Ser. A Biol. Sci. Med. Sci. 2014;69:547–58.CrossRefGoogle Scholar
  10. 10.
    Beaudart C, Reginster JY, Slomian J, et al. Estimation of sarcopenia prevalence using various assessment tools. Exp. Gerontol. 2015;61:31–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Beaudart C, Reginster J-Y, Slomian J, Buckinx F, Locquet M, Bruyère O. Prevalence of sarcopenia: the impact of different diagnostic cut-off limits. J. Musculoskelet. Neuronal Interact. 2014;14:425–31.PubMedGoogle Scholar
  12. 12.
    Dupuy C, Lauwers-Cances V, Guyonnet S, et al. Searching for a relevant definition of sarcopenia: results from the cross-sectional EPIDOS study. J. Cachexia. Sarcopenia Muscle. 2015.https://doi.org/wiley.com/10.1002/jcsm.12021. Google Scholar
  13. 13.
    Dodds RM, Roberts HC, Cooper C, Sayer AA. The Epidemiology of Sarcopenia. J. Clin. Densitom. Europe PMC Funders. 2015;18:461–6.CrossRefGoogle Scholar
  14. 14.
    Beaudart C, Zaaria M, Pasleau F, Reginster J-Y, Bruyère O. Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. Wright JM,editor. PLoS One. 2017;12:e0169548.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Vandervoort AA. Aging of the human neuromuscular system. Muscle Nerve. 2002;25:17–25.CrossRefPubMedGoogle Scholar
  16. 16.
    Kamel HK, Maas D, Duthie EH. Role of hormones in the pathogenesis and management of sarcopenia. Drugs Aging. 2002;19:865–77.CrossRefPubMedGoogle Scholar
  17. 17.
    Schaap LA, Pluij. SMF, Deeg DJH, Visser M. Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and Strength. Am. J. Med. 2006;119:526e9–526e17.CrossRefGoogle Scholar
  18. 18.
    Crowley K. Sleep and Sleep Disorders in Older Adults. Neuropsychol. Rev. 2011;21:41–53.CrossRefPubMedGoogle Scholar
  19. 19.
    Ancoli-Israel S, Cooke JR. Prevalence and Comorbidity of Insomnia and Effect on Functioning in Elderly Populations. J. Am. Geriatr. Soc. 2005;53:S264–71.CrossRefPubMedGoogle Scholar
  20. 20.
    Piovezan RD, Abucham J, do. Santos RVT, Mello MT, Tufik S, Poyares D. The impact of sleep on age-related sarcopenia: Possible connections and clinical implications. Ageing Res. Rev. 2015;23:210–20.CrossRefPubMedGoogle Scholar
  21. 21.
    Chien M-Y, Wang L-Y, Chen H-C. The Relationship of Sleep Duration with Obesity and Sarcopenia in Community-Dwelling Older Adults. Gerontology. 2015;61:399–406.CrossRefPubMedGoogle Scholar
  22. 22.
    Hu X, Jiang J, Wang H, Zhang L, Dong B, Yang M. Association between sleep duration and sarcopenia among community-dwelling older adults. Medicine (Baltimore). 2017;96:e6268.CrossRefGoogle Scholar
  23. 23.
    Ethgen O, Beaudart C, Buckinx F, Bruyère O, Reginster JY. The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. Calcif. Tissue Int. 2017;100:229–34.CrossRefPubMedGoogle Scholar
  24. 24.
    Beaudart C, Reginster JY, Petermans J, et al. Quality of life and physical components linked to sarcopenia: The SarcoPhAge study. Exp. Gerontol. 2015;69:103–10.CrossRefPubMedGoogle Scholar
  25. 25.
    Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J. Am. Geriatr. Soc. 1992;40:922–35.CrossRefPubMedGoogle Scholar
  26. 26.
    Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A. Biol. Sci. Med. Sci. 2001;56:M146–56.CrossRefPubMedGoogle Scholar
  27. 27.
    Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40:423–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J. Gerontol. A. Biol. Sci. Med. Sci. 2000;55:M221–31.CrossRefPubMedGoogle Scholar
  29. 29.
    Blais FC, Gendron L, Mimeault V, Morin CM. Evaluation de l’insomnie: validation de trois questionnaires. L’ Encéphale. Elsevier Masson. 1997;23:447–53.Google Scholar
  30. 30.
    Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.CrossRefPubMedGoogle Scholar

Copyright information

© Serdi and Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Médéa Locquet
    • 1
    • 2
    • 3
  • C. Beaudart
    • 1
    • 2
  • L. Delandsheere
    • 1
    • 2
  • J.-Y. Reginster
    • 1
    • 2
  • O. Bruyère
    • 1
    • 2
  1. 1.Department of Public Health, Epidemiology and Health EconomicsUniversity of Liège Teaching HospitalLiègeBelgium
  2. 2.World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and AgingUniversity of LiègeLiègeBelgium
  3. 3.Quartier HôpitalLiègeBelgium

Personalised recommendations